Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.07

-3.4%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (24160)	8/7/1998 10:02:00 PM
From: Machaon	Read Replies (2) of 32384

<< Bob, Maybe AGN's is finished selling at prices below $10. >> I don't understand what you mean? On another topic: From a June 30th Ligand news release: "Phase II trials with Panretin capsules are ongoing in breast and pediatric cancers, and in bronchial metaplasia. Phase II trials in myelodysplastic syndrome and in severe plaque psoriasis have been completed. The results of the ongoing studies are expected to be announced in 1998 and may support additional studies upon which additional NDAs could be based." We haven't heard anything from the "completed" Phase II trials for myel. syndrome and psoriasis yet. Could this mean that the results were not significant, for those two disease applications? Thanks, Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next